Empyema in a patient treated with infliximab: it is not what it seems
Reduced IgG levels can be the result of long term prednisone treatment or chronic infection. 1 Isolated IgG2 subclass deficiency may result in enhanced susceptibility to encapsulated bacteria. 2 Another report suggests an increased susceptibility to invasive pneumococcal disease in homozygotes for M...
Gespeichert in:
Veröffentlicht in: | Annals of the rheumatic diseases 2005-11, Vol.64 (11), p.1657-1658 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Reduced IgG levels can be the result of long term prednisone treatment or chronic infection. 1 Isolated IgG2 subclass deficiency may result in enhanced susceptibility to encapsulated bacteria. 2 Another report suggests an increased susceptibility to invasive pneumococcal disease in homozygotes for MBL codon variants. 3 It is tempting to speculate that the immunomodulating effect of infliximab contributed to the two episodes of thoracic empyema. |
---|---|
ISSN: | 0003-4967 1468-2060 |
DOI: | 10.1136/ard.2004.034959 |